Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: J Consult Clin Psychol. 2020 Aug;88(8):738–756. doi: 10.1037/ccp0000550

Table 3a.

Post-treatment feasibility, acceptability, and parent-reported outcome data

Variable ICT (n=29) CET (n=25) Effect size η2p Cohen’s d BF01 p

M SD M SD
Medication Changes (Stop/No/Add) 1/20/8 1/18/6 -- -- 12.70 .95, ns
Caregiver Satisfaction (CSQ-8) 3.63 0.44 3.47 0.54 0.28 1.90 .22, ns
NICT Expectancies Questionnaire (Mean Scores)
 Overall Expectancies 4.65 1.24 4.61 0.83 .000 0.03 3.38 .89, ns
 Concentration/distractibility expectancies 4.64 1.33 4.54 0.92 .001 0.06 3.30 .77, ns
 Cognitive abilities expectancies 4.76 1.20 4.67 0.84 .001 0.07 3.29 .77, ns
Training Time (minutes) 495.02 235.72 658.32 389.04 .044 −0.43 0.84 .06, ns
System Usability Scale 82.14 15.90 73.50 17.84 .046 0.44 0.88 .07, ns
BASC-3 Attention Problems (parent T-score) 64.10 7.23 63.72 7.82 .004 0.13 1.55 .14, ns
BASC-3 Hyperactivity (parent T-score) 58.72 10.65 62.20 10.58 .001 0.06 3.51 .84, ns
ADHD-RS-5 Attention Problems (parent T-score) 61.72 6.09 61.32 7.34 .010 0.20 3.05 .47, ns
ADHD-RS-5 Hyperactive/Impulsive (parent T-score) 59.34 8.17 61.08 6.66 .000 0.02 3.41 .89, ns

Note. Effect sizes and statistical tests reflect control for pre-treatment scores on the same measure for BASC-3, ADHD-RS-5, and CSI-IV. Training time is measured by the CET/ICT software as time spent actively playing the training games. BF = Bayes Factor; CET = Central Executive Training; ICT = Inhibitory Control Training; Medication Changes (Stop = Discontinued Medication During Study, No = No Changes Reported, Add = Started Medication During Study).